1. Pink Sheet

EU Regulators Concerned By Mushrooming Of Small COVID-19 Trials

Want Better Use Of The Short Window Of Opportunity

 
• By Vibha Sharma

Based on experience from earlier epidemics, EU regulators are concerned that the high number of COVID-19 trials starting in a confined geography at the peak of the coronavirus pandemic will not be able to enrol patients up to their pre-established sample size. 

Coronavirus
Small, individual COVID-19 Trials May Not Generate Conclusive Evidence • Source: Shutterstock

Senior EU regulators have expressed concern over the “unfortunate” mushrooming of stand-alone COVID-19 clinical trials and observational studies of single-agent interventions despite clear advice to the contrary.

The regulators say that in any pandemic or epidemic - as was seen in the recent Ebola outbreak in West Africa - “the window of opportunity to run

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D